Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Authors
»
Aaron Lorenzo
Articles by Aaron Lorenzo
Miikana Comes Together As An Oncology Drug Developer
Oct. 8, 2003
By
Aaron Lorenzo
Flamel Raises $62M Through Sale Of Its Common Shares
Oct. 8, 2003
By
Aaron Lorenzo
Ingenium Broadens Relationship With Elan For Target Validation
Oct. 7, 2003
By
Aaron Lorenzo
Ingenium Broadens Relationship With Elan For Target Validation
Oct. 7, 2003
By
Aaron Lorenzo
Flamel Raises $62M Through Sale Of Its Common Shares
Oct. 6, 2003
By
Aaron Lorenzo
Ariad Gets $41M In Private Sale For Drug Development
Oct. 6, 2003
By
Aaron Lorenzo
Ariad Gets $41M In Private Sale For Drug Development
Oct. 6, 2003
By
Aaron Lorenzo
Flamel Raises $62M Through Sale Of Its Common Shares
Oct. 6, 2003
By
Aaron Lorenzo
Biosyn Eyeing $10M For HIV Product Development Program
Oct. 3, 2003
By
Aaron Lorenzo
Biosyn Eyeing $10M For HIV Product Development Program
Oct. 3, 2003
By
Aaron Lorenzo
Previous
1
2
…
169
170
171
172
173
174
175
176
177
…
237
238
Next
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe